THE ROLE OF HEXAMIDINE DIISETHIONATE (ZAMIDINE®) 1MG/ML 0.6ML EYE DROPS IN THE PROPHYLAXIS OF SURGERY OFTALMIC

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Jan 8, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the use of a specific eye drop called Zamidine® to help prevent infections in patients undergoing certain eye surgeries, especially those with a history of repeated eye infections known as conjunctivitis. Researchers are looking for patients aged 18 and older who are scheduled for various eye surgeries, such as cataract surgery or glaucoma surgery, and who have had recurrent conjunctivitis. Participants will need to provide written consent to join the study.

If you decide to participate, you can expect to have some swabs taken from your eye before and during your surgery to check for bacteria and other organisms. This will help the researchers understand how well Zamidine® works in preventing infections. Follow-up information will also be collected after your surgery to see how you are doing. Overall, this trial aims to ensure safer surgical outcomes for patients with recurrent eye infections.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 18 years or older, male and female;
• • 2. Patient requiring ophthalmic surgery (intravitreal injections, glaucoma surgery, cataract surgery, vitrectomy, combined cataract and vitrectomy, corneal transplantation) and in need of antiseptic surgical prophylaxis (e.g., Zamidine®)
• • 3. Positive history of recurrent conjunctivitis in the eye requiring surgery.
• • 4. Written informed consent.
• Exclusion Criteria:
• • 1. Age \< 18 years;
• • 2. Refusal to give informed consent.